The largest database of trusted experimental protocols

Human on targetplus druggable genome sirna library

Manufactured by Greiner

The Human ON-TARGETplus druggable genome siRNA library is a collection of small interfering RNA (siRNA) molecules designed to target the human druggable genome. The library is intended for use in functional genomics research to study gene function and identify potential drug targets.

Automatically generated - may contain errors

2 protocols using human on targetplus druggable genome sirna library

1

High-throughput siRNA Screening for Druggable Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Dharmacon® human ON-TARGETplus druggable genome siRNA library (7,518 genes total with pools of four unique siRNAs targeting each gene) was aliquoted in triplicate into black, clear-bottom, 384-well plates (Greiner, 781091) for a final diluted siRNA concentration of 25 nM. Control siRNAs targeting JAM-A (receptor for reovirus), reovirus μ2, reovirus μNS, and a non-targeting control were seeded into empty wells. As a control for transfection efficiency, wells also were seeded with the AllStars Cell Death control siRNA (Qiagen). Lipofectamine® RNAiMax transfection reagent was diluted in Opti-MEM reduced-serum medium, and aliquoted into each well (0.07 μL RNAiMax per well). Following a 15-min incubation at room temperature (RT), the siRNA/lipid solution was combined with 5 × 102 HBMECs per well in complete RPMI medium. Cells were incubated at 37°C for 48 h to allow efficient target knockdown.
+ Open protocol
+ Expand
2

High-throughput siRNA Screening for Druggable Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Dharmacon® human ON-TARGETplus druggable genome siRNA library (7,518 genes total with pools of four unique siRNAs targeting each gene) was aliquoted in triplicate into black, clear-bottom, 384-well plates (Greiner, 781091) for a final diluted siRNA concentration of 25 nM. Control siRNAs targeting JAM-A (receptor for reovirus), reovirus μ2, reovirus μNS, and a non-targeting control were seeded into empty wells. As a control for transfection efficiency, wells also were seeded with the AllStars Cell Death control siRNA (Qiagen). Lipofectamine® RNAiMax transfection reagent was diluted in Opti-MEM reduced-serum medium, and aliquoted into each well (0.07 μL RNAiMax per well). Following a 15-min incubation at room temperature (RT), the siRNA/lipid solution was combined with 5 × 102 HBMECs per well in complete RPMI medium. Cells were incubated at 37°C for 48 h to allow efficient target knockdown.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!